Latest Content


10 Years of CAR-T: What Does the Future Hold for CAR-T?

As our month of celebrating ’10 years of CAR-T’ nears its end,  we explore what to expect from CAR-T in the coming years.
20th May 2022

Reducing Manufacturing Bottlenecks: Nailing Your Process Development and Manufacturing Enhancement Early

Join global leaders in the development and deployment of cell and gene therapies as they discuss assistive technological advancements, the need for standardization, and the implications on the end-user and patient of the necessary quality, speed and cost modifiers for advanced therapies.
19th May 2022

Virica Biotech Receives Funding from Canadian Government to Support the Re-Development of the Worlds First Ever Gene Therapy

Virica Biotech has announced collaboration with the Government of Canada to support the manufacturing of an AAV-LPL (lipoprotein lipase) gene therapy to treat lipoprotein lipase deficiency.
18th May 2022

Industrializing Next Generation Therapies: Resource Optimization & Customer Experience

In this webinar, discover how to better organize your operations to treat more patients and scale confidently to commercial success.
17th May 2022
LIVE ON 16 JUNE 2022

ASGCT: Highlights From the Program

Ryan Leahy summarizes what he’s looking forward to from the ASGCT program, from pre-event workshops to highlights from the agenda.
16th May 2022
Washington, DC

Advanced Therapies Week Content Library

Following Advanced Therapies Week 2022, we have put together a short library of some of our sponsored content, filmed at the conference. Watch presentations, briefings and exclusive interviews to catch up on the action.
12th May 2022
Content services

Your Content Marketing Agency for Advanced Therapies

From creation to distribution, Phacilitate is a full service content marketing agency
Our eBooks & Infographics
What’s preventing developers from designing mechanistically relevant assays? This report examines this question, focusing on the identification and measurement of appropriate CQAs, the value of fit-for-purpose analytics technologies and what the future of CGT manufacturing analytics should look like.
May 2022 marks the month 17-year-old Emily Whitehead, the first pediatric patient in the world to receive CAR-T cell therapy, celebrates a momentous milestone: 10 years’ cancer free. All month Phacilitate will be joining to celebrate 10 years of CAR-T!
Welcome to Phacilitate’s first Women in Advanced Therapies eBook, commemorating International Women’s Day 2022.
A snapshot of the industry’s approach to commercialisation, presented as a handy infographic.
A collection of the outcomes from the roundtables and panels that took place at Advanced Therapies Connect 2020
This e-book examines 15 of the world’s leading immuno-oncology biotechnology companies, providing you with an at-a-glance view plus more detailed information on how their pipelines are developing.
2017 was a milestone year for the immuno-oncology industry. There was big headline news; Novartis’ Kymriah and Kite’s submission of their ZUMA-1 trial to European regulators, as well as numerous incremental wins.
The pace of innovation across cell and gene therapy biotechs is gaining speed and it can be challenging to keep track of scientific developments, new technologies and who might be looking for their next big partnership.
A guide to the non-dilutive funding applications that are open or opening soon from the US and Europe.
What are the key commercialisation challenges associated with bringing a cell and/or gene therapy to a commercial scale?